← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 8, 2021Last known activity
May 20, 2024
Timeline
2010s
- Jun 1, 2019
HiberCell, Inc.— Founded
Drugs by trial phase (8 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Recent trials (9)
- NCT06285890CollaboratorPhase 1May 20, 2024
- NCT06234605Lead sponsorPhase 1Apr 29, 2024
- NCT05484011Lead sponsorPhase 1Dec 31, 2022
- NCT05121948Lead sponsorPhase 1Jan 31, 2022
- NCT05121948Study directorPhase 1Jan 31, 2022
- NCT05159778Lead sponsorPhase 2Nov 9, 2021
- NCT04995094Lead sponsorPhase 2Aug 15, 2021
- NCT04834778Lead sponsorPhase 1Jun 8, 2021
- NCT04834778Study directorPhase 1Jun 8, 2021
Details
- Founded
- New York, NY, US Jun 1, 2019
- Last known activity
- May 20, 2024